Dan Lane
Overview
Explore the profile of Dan Lane including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
18
Citations
161
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Bate N, Lane D, Evans S, Salim F, Allcock N, Haigh R, et al.
JACS Au
. 2025 Feb;
5(2):747-755.
PMID: 40017752
Mass spectrometry (MS) is a potentially powerful approach for the diagnostic detection of SARS-CoV-2 and other viruses. However, MS detection is compromised when viral antigens are present at low concentrations,...
2.
Jenkins S, Cross A, Osman H, Salim F, Lane D, Bernieh D, et al.
J Hum Hypertens
. 2024 Aug;
38(10):719-727.
PMID: 39138350
Hypertension is the leading modifiable risk factor for cardiovascular disease, but less than 50% have their blood pressure controlled. A possible avenue to support hypertension management is a holistic approach,...
3.
Lane D, Allsopp R, Holmes C, Slingsby O, Jukes-Jones R, Bird P, et al.
Clin Chem Lab Med
. 2024 Jan;
62(6):1206-1216.
PMID: 38253336
Objectives: Many reverse transcription polymerase chain reaction (RT-PCR) methods exist that can detect SARS-CoV-2 RNA in different matrices. RT-PCR is highly sensitive, although viral RNA may be detected long after...
4.
Osman H, Lane D, Bernieh D, Seidu S, Patel P, Khunti K, et al.
Kidney Int Rep
. 2023 Dec;
8(12):2818-2821.
PMID: 38106590
No abstract available.
5.
Hallqvist J, Lane D, Shapanis A, Davis K, Heywood W, Doykov I, et al.
Clin Chem Lab Med
. 2022 Nov;
61(2):302-310.
PMID: 36395058
Objectives: During 2020, the UK's Department of Health and Social Care (DHSC) established the Moonshot programme to fund various diagnostic approaches for the detection of SARS-CoV-2, the pathogen behind the...
6.
Lane D, Beishon L, Sharma V, Salim F, Sze S, Timmins M, et al.
J Stroke Cerebrovasc Dis
. 2022 Jul;
31(9):106665.
PMID: 35901588
Introduction: Transient ischaemic attack (TIA) clinics are important for secondary prevention of fatal or disabling stroke. Non-adherence to prescribed medications is an important reason for treatment failure but difficult to...
7.
Lane D, Lawson A, Burns A, Azizi M, Burnier M, Jones D, et al.
Hypertension
. 2021 Nov;
79(1):12-23.
PMID: 34739765
Nonadherence to antihypertensive medication is common, especially in those with apparent treatment-resistant hypertension (true treatment-resistant hypertension requires exclusion of nonadherence), and its routine detection is supported by clinical guidelines. Chemical...
8.
Van Puyvelde B, Van Uytfanghe K, Tytgat O, Van Oudenhove L, Gabriels R, Bouwmeester R, et al.
JACS Au
. 2021 Jul;
1(6):750-765.
PMID: 34254058
Rising population density and global mobility are among the reasons why pathogens such as SARS-CoV-2, the virus that causes COVID-19, spread so rapidly across the globe. The policy response to...
9.
Gupta P, Voors A, Patel P, Lane D, Anker S, Cleland J, et al.
Eur J Heart Fail
. 2021 Mar;
23(7):1182-1190.
PMID: 33759308
Aims: Liquid chromatography-mass spectrometry (LC-MS/MS) is an objective new technique to assess non-adherence to medications. We used this method to study the prevalence, predictors and outcomes of non-adherence in patients...
10.
Lane D, Patel P, Khunti K, Gupta P
Patient Prefer Adherence
. 2019 May;
13:537-547.
PMID: 31043772
Cardiometabolic diseases are among the most prevalent and harmful conditions worldwide. They are complex, comorbid conditions that require polypharmacy - a known contributor to non-adherence in cardiovascular disease (CVD) and...